$22.19
00.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Rapport Therapeutics (RAPP) Forecast
NewsEarningsRapport Therapeutics (RAPP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRapport Therapeutics (NASDAQ:RAPP) Stock Quotes, Forecast and News Summary
Rapport Therapeutics Stock (NASDAQ: RAPP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Rapport Therapeutics (RAPP) stock?
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Who are Rapport Therapeutics (RAPP) competitors?
Other companies in Rapport Therapeutics’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Bioage Labs (NASDAQ:BIOA).
What is the forecast, or price target, for Rapport Therapeutics (RAPP) stock?
Rapport Therapeutics has a consensus price target of $37.33.
What is the current price for Rapport Therapeutics (RAPP)?
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $22.19 last updated November 20, 2024 at 4:00 PM EST.
Does Rapport Therapeutics (RAPP) pay a dividend?
There are no upcoming dividends for Rapport Therapeutics.
When is Rapport Therapeutics (NASDAQ:RAPP) reporting earnings?
Rapport Therapeutics’s Q4 earnings are confirmed for Monday, February 10, 2025.
Is Rapport Therapeutics (RAPP) going to split?
There is no upcoming split for Rapport Therapeutics.
What sector and industry does Rapport Therapeutics (RAPP) operate in?
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.